BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32807492)

  • 1. ReN VM spheroids in matrix: A neural progenitor three-dimensional in vitro model reveals DYRK1A inhibitors as potential regulators of radio-sensitivity.
    Wan X; Wu X; Hill MA; Ebner DV
    Biochem Biophys Res Commun; 2020 Oct; 531(4):535-542. PubMed ID: 32807492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice.
    Naert G; Ferré V; Meunier J; Keller E; Malmström S; Givalois L; Carreaux F; Bazureau JP; Maurice T
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):2170-82. PubMed ID: 26381812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation.
    Göckler N; Jofre G; Papadopoulos C; Soppa U; Tejedor FJ; Becker W
    FEBS J; 2009 Nov; 276(21):6324-37. PubMed ID: 19796173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A.
    Nguyen TL; Duchon A; Manousopoulou A; Loaëc N; Villiers B; Pani G; Karatas M; Mechling AE; Harsan LA; Limanton E; Bazureau JP; Carreaux F; Garbis SD; Meijer L; Herault Y
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30115750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational Design and Identification of Harmine-Inspired, N-Heterocyclic DYRK1A Inhibitors Employing a Functional Genomic In Vivo Drosophila Model System.
    Huizar FJ; Hill HM; Bacher EP; Eckert KE; Gulotty EM; Rodriguez KX; Tucker ZD; Banerjee M; Liu H; Wiest O; Zartman J; Ashfeld BL
    ChemMedChem; 2022 Feb; 17(4):e202100512. PubMed ID: 34994084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro.
    Mohamed AA; Thomsen A; Follo M; Zamboglou C; Bronsert P; Mostafa H; Amen A; Mekawy M; Grosu AL; Brunner TB
    Strahlenther Onkol; 2021 Jan; 197(1):27-38. PubMed ID: 32705304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth.
    Pozo N; Zahonero C; Fernández P; Liñares JM; Ayuso A; Hagiwara M; Pérez A; Ricoy JR; Hernández-Laín A; Sepúlveda JM; Sánchez-Gómez P
    J Clin Invest; 2013 Jun; 123(6):2475-87. PubMed ID: 23635774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of DYRK1A activity inhibition on development of neuronal progenitors isolated from Ts65Dn mice.
    Mazur-Kolecka B; Golabek A; Kida E; Rabe A; Hwang YW; Adayev T; Wegiel J; Flory M; Kaczmarski W; Marchi E; Frackowiak J
    J Neurosci Res; 2012 May; 90(5):999-1010. PubMed ID: 22252917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Kinase-Selective, Harmine-Based DYRK1A Inhibitors that Induce Pancreatic Human β-Cell Proliferation.
    Kumar K; Wang P; Sanchez R; Swartz EA; Stewart AF; DeVita RJ
    J Med Chem; 2018 Sep; 61(17):7687-7699. PubMed ID: 30059217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses.
    Härmä V; Virtanen J; Mäkelä R; Happonen A; Mpindi JP; Knuuttila M; Kohonen P; Lötjönen J; Kallioniemi O; Nees M
    PLoS One; 2010 May; 5(5):e10431. PubMed ID: 20454659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Analysis of Negative Growth Control Implicates the DREAM Complex in Cancer Cell Dormancy.
    MacDonald J; Ramos-Valdes Y; Perampalam P; Litovchick L; DiMattia GE; Dick FA
    Mol Cancer Res; 2017 Apr; 15(4):371-381. PubMed ID: 28031411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro co-culture model of medulloblastoma and human neural stem cells for drug delivery assessment.
    Ivanov DP; Parker TL; Walker DA; Alexander C; Ashford MB; Gellert PR; Garnett MC
    J Biotechnol; 2015 Jul; 205():3-13. PubMed ID: 25592050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor.
    Kumar K; Wang P; Wilson J; Zlatanic V; Berrouet C; Khamrui S; Secor C; Swartz EA; Lazarus M; Sanchez R; Stewart AF; Garcia-Ocana A; DeVita RJ
    J Med Chem; 2020 Mar; 63(6):2986-3003. PubMed ID: 32003560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The small molecule harmine regulates NFATc1 and Id2 expression in osteoclast progenitor cells.
    Egusa H; Doi M; Saeki M; Fukuyasu S; Akashi Y; Yokota Y; Yatani H; Kamisaki Y
    Bone; 2011 Aug; 49(2):264-74. PubMed ID: 21504804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of harmine and β-carboline analogs from a high-throughput screen of an approved drug collection; profiling as differential inhibitors of DYRK1A and monoamine oxidase A and for in vitro and in vivo anti-cancer studies.
    Tarpley M; Oladapo HO; Strepay D; Caligan TB; Chdid L; Shehata H; Roques JR; Thomas R; Laudeman CP; Onyenwoke RU; Darr DB; Williams KP
    Eur J Pharm Sci; 2021 Jul; 162():105821. PubMed ID: 33781856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional culture of single embryonic stem-derived neural/stem progenitor cells in fibrin hydrogels: neuronal network formation and matrix remodelling.
    Bento AR; Quelhas P; Oliveira MJ; Pêgo AP; Amaral IF
    J Tissue Eng Regen Med; 2017 Dec; 11(12):3494-3507. PubMed ID: 28032468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the Three-Dimensional Structure of Adherent Gingival Fibroblasts and Spheroids via a Fibrous Protein-Based Hydrogel Cover.
    Kaufman G; Nunes L; Eftimiades A; Tutak W
    Cells Tissues Organs; 2016; 202(5-6):343-354. PubMed ID: 27578009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a magnetic 3D spheroid platform with potential application for high-throughput drug screening.
    Guo WM; Loh XJ; Tan EY; Loo JS; Ho VH
    Mol Pharm; 2014 Jul; 11(7):2182-9. PubMed ID: 24842574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-time viability and apoptosis kinetic detection method of 3D multicellular tumor spheroids using the Celigo Image Cytometer.
    Kessel S; Cribbes S; Bonasu S; Rice W; Qiu J; Chan LL
    Cytometry A; 2017 Sep; 91(9):883-892. PubMed ID: 28618188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.